Skip to main content
    C

    Colgate-Palmolive Company (CL)

    Official site

    CONSUMER DEFENSIVE • HOUSEHOLD & PERSONAL PRODUCTS • NYSE

    $100.98
    +1.32 (+1.32%)

    Market Cap: $79.23B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Colgate-Palmolive Company (CL) Earnings: Report Dates and Results

    Updated Oct 30, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Colgate-Palmolive Company (CL) is expected to report earnings on Jan 28, 2027. In the quarter ended Sep 30, 2026, Colgate-Palmolive Company reported EPS of $0.97, above the $0.92 estimate. It beat the EPS estimate in each of the last 15 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    70%(28/40)
    Avg Surprise
    +2.43%
    Streak
    15 Q

    Upcoming Estimates

    Reports Jan 28, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$1.01
    Range$0.94 - $1.07
    21 analysts
    Revenue Consensus
    $5.54B
    Range$5.22B - $5.72B
    18 analysts
    Reports Apr 29, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$0.97
    Range$0.89 - $1.02
    13 analysts
    EPS Revisions
    0
    5
    30d
    EPS Estimate DriftChange to current
    90d ago$0.99-2.0%
    60d ago$0.99-2.0%
    30d ago$0.99-1.9%
    7d ago$0.98-1.0%
    Current$0.97
    Revenue Consensus
    $5.44B
    Range$5.35B - $5.48B
    9 analysts

    Next Report

    CL has an expected report date of Jan 28, 2027. Analysts' consensus for the quarter ending Dec 31, 2026 is 6.3% above the $0.95 reported for the quarter ended Dec 31, 2025.

    CL Earnings Call

    The latest CL earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, CL beat 28, missed 1 and matched 11. Revenue for the quarter ended Sep 30, 2026 was $5.37B, up 4.7% from $5.13B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.97$0.92$0.89 - $0.95+5.43%Beat+6.6%171 up, 1 downOct 30, 2026$5.37B
    Jun 30, 2026$0.99$0.95$0.91 - $0.97+4.21%Beat+7.6%170 up, 1 downJul 31, 2026$5.36B
    Mar 31, 2026$0.97$0.94$0.92 - $0.97+3.19%Beat+6.6%156 up, 5 downMay 1, 2026$5.32B
    Dec 31, 2025$0.95$0.91$0.89 - $0.93+4.40%Beat+4.4%152 up, 3 downJan 30, 2026$5.23B
    Sep 30, 2025$0.91$0.89$0.86 - $0.91+2.25%Beat0.0%161 up, 13 downOct 31, 2025$5.13B
    Jun 30, 2025$0.92$0.89$0.85 - $0.92+3.37%Beat+1.1%155 up, 2 downAug 1, 2025$5.11B
    Mar 31, 2025$0.91$0.86$0.83 - $0.89+5.81%Beat+5.8%181 up, 15 downApr 25, 2025$4.91B
    Dec 31, 2024$0.91$0.89$0.87 - $0.92+2.25%Beat+4.6%161 up, 9 downJan 31, 2025$4.95B
    Sep 30, 2024$0.91$0.88$0.87 - $0.91+3.41%Beat+5.8%173 up, 0 downOct 25, 2024$5.03B
    Jun 30, 2024$0.91$0.87$0.84 - $0.89+4.60%Beat+18.2%185 up, 2 downJul 26, 2024$5.06B
    Mar 31, 2024$0.86$0.81$0.76 - $0.86+6.17%Beat+17.8%166 up, 0 downApr 26, 2024$5.07B
    Dec 31, 2023$0.87$0.85$0.80 - $0.88+2.35%Beat+13.0%174 up, 0 downJan 26, 2024$4.95B
    Sep 30, 2023$0.86$0.80$0.78 - $0.82+7.50%Beat+16.2%164 up, 1 downOct 27, 2023$4.92B
    Jun 30, 2023$0.77$0.75N/A+2.67%Beat+6.9%143 up, 0 downJul 28, 2023$4.82B
    Mar 31, 2023$0.73$0.70$0.64 - $0.75+4.29%Beat-1.4%172 up, 0 downApr 28, 2023$4.77B
    Dec 31, 2022$0.77$0.77$0.74 - $0.790.00%In line-2.5%185 up, 1 downJan 27, 2023$4.63B
    Sep 30, 2022$0.74$0.73$0.69 - $0.76+1.37%Beat-8.6%172 up, 1 downOct 28, 2022$4.46B
    Jun 30, 2022$0.72$0.71$0.68 - $0.73+1.41%Beat-10.0%174 up, 1 downJul 29, 2022$4.48B
    Mar 31, 2022$0.74$0.75$0.70 - $0.78-1.33%Miss-7.5%180 up, 1 downApr 29, 2022$4.40B
    Dec 31, 2021$0.79$0.79$0.74 - $0.830.00%In line+2.6%171 up, 1 downJan 28, 2022$4.40B
    Sep 30, 2021$0.81$0.80$0.77 - $0.85+1.25%Beat+2.5%150 up, 0 downOct 29, 2021$4.41B
    Jun 30, 2021$0.80$0.80$0.75 - $0.830.00%In line+8.1%17N/AJul 30, 2021$4.26B
    Mar 31, 2021$0.80$0.79$0.75 - $0.82+1.27%Beat+6.7%17N/AApr 30, 2021$4.34B
    Dec 31, 2020$0.77$0.76$0.74 - $0.79+1.32%Beat+5.5%18N/AJan 29, 2021$4.32B
    Sep 30, 2020$0.79$0.70$0.67 - $0.72+12.86%Beat+11.3%16N/AOct 30, 2020$4.15B
    Jun 30, 2020$0.74$0.69$0.64 - $0.75+7.25%Beat+2.8%17N/AJul 31, 2020$3.90B
    Mar 31, 2020$0.75$0.73$0.68 - $0.82+2.74%Beat+11.9%15N/AMay 1, 2020$4.10B
    Dec 31, 2019$0.73$0.73$0.71 - $0.760.00%In line-1.4%17N/AJan 31, 2020$4.01B
    Sep 30, 2019$0.71$0.70$0.68 - $0.71+1.43%Beat-1.4%18N/ANov 1, 2019$3.93B
    Jun 30, 2019$0.72$0.72$0.71 - $0.750.00%In line-6.5%18N/AJul 26, 2019$3.87B
    Mar 31, 2019$0.67$0.66$0.63 - $0.69+1.52%Beat-9.5%19N/AApr 26, 2019$3.88B
    Dec 31, 2018$0.74$0.73$0.72 - $0.75+1.37%Beat-1.3%18N/AJan 25, 2019$3.81B
    Sep 30, 2018$0.72$0.72$0.70 - $0.740.00%In line-1.4%17N/AOct 26, 2018$3.85B
    Jun 30, 2018$0.77$0.77$0.75 - $0.800.00%In line+6.9%17N/AJul 27, 2018$3.89B
    Mar 31, 2018$0.74$0.73$0.70 - $0.74+1.37%Beat+10.4%16N/AApr 27, 2018$4.00B
    Dec 31, 2017$0.75$0.75$0.72 - $0.770.00%In line0.0%19N/AJan 26, 2018$3.89B
    Sep 30, 2017$0.73$0.73$0.71 - $0.750.00%In line0.0%17N/AOct 27, 2017$3.97B
    Jun 30, 2017$0.72$0.72$0.70 - $0.740.00%In line+2.9%18N/AJul 21, 2017$3.83B
    Mar 31, 2017$0.67$0.66N/A+1.52%Beat+6.3%N/AN/AApr 28, 2017$3.76B
    Dec 31, 2016$0.75$0.75N/A0.00%In line+2.7%N/AN/AJan 27, 2017$3.72B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $3.69, up 2.8% from the year before. It was $2.81 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$3.69+2.8%
    Dec 31, 2024$3.59+11.1%
    Dec 31, 2023$3.23+8.8%
    Dec 31, 2022$2.97-7.2%
    Dec 31, 2021$3.20+4.9%
    Dec 31, 2020$3.05+7.8%
    Dec 31, 2019$2.83-4.7%
    Dec 31, 2018$2.97+3.5%
    Dec 31, 2017$2.87+2.1%
    Dec 31, 2016$2.81N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 10,000 words across 19 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20269,99019
    2026Q2Jun 30, 20269,23321
    2026Q1Mar 31, 20266,07515
    2025Q4Dec 31, 20257,29919
    2025Q3Sep 30, 20258,01220
    2025Q2Jun 30, 20256,68117
    2025Q1Mar 31, 202510,42320
    2024Q4Dec 31, 20249,99821

    2026Q3 Earnings Call

    Opening remarks

    Claire Ross Executive Vice President, Investor Relations Good morning, and welcome to our Third Quarter 2026 Earnings Release Conference Call. This is Claire Ross, Executive Vice President, Investor Relations. Today's conference call will include forward-looking statements. Actual results could differ materially from these statements. Forward-looking statements inherently involve risks and uncertainties and are made on the basis of our views and assumptions at this time. Please refer to the third quarter earnings press release and our most recent filings with the SEC, including our 2025 annual report on Form 10-K and our subsequent SEC filings, all available on our website, for a discussion of the factors that could cause actual results to differ materially from these statements. These remarks also include a discussion of non-GAAP financial measures, which exclude certain items from reported results, including those identified in tables four, six, seven, eight, and nine of the third quarter earnings press release. A full reconciliation to the corresponding GAAP financial measures and related definitions is included in the earnings press release. Joining me on the call this morning are Noel Wallace, Chairman, President, and Chief Executive Officer, and Stan Sutula, Chief Financial Officer. Noel will provide you with his thoughts on our results and our 2026 outlook. We will then open it up for Q&A.

    Noel Wallace Chairman, President, and CEO Thanks, Claire, and good morning, everyone. A few thoughts. We are clearly pleased to have delivered another quarter of solid top- and bottom-line growth, particularly in the context of the continued global volatility we are seeing. Our strong results were broad-based, with organic sales growth in all four of our categories and four of our five divisions. We delivered solid gross margin expansion in a challenging cost environment. Base business EPS came in ahead of our expectations, even as we continue to increase our advertising. We are driving operating leverage through our productivity programs, including funding-the-growth and the Strategic Growth and Productivity Program, which drove lower costs. Our balance sheet and cash flow performance through the third quarter was also very strong, with free cash flow up 7%, and we have returned $2.2 billion to shareholders year-to-date. Our strong on-the-ground execution, coupled with our continued investment in our AI capabilities, helped drive our performance. As was the case last quarter, sales growth was led by emerging markets, which were up mid-single digits, driven by India, Brazil, and China. We also had strong contributions from our European markets, where science-based premium innovation and our omni-channel demand generation model have led to record market shares. Our Hill's business had a very strong quarter across both therapeutic and wellness businesses. We are pleased with our global momentum, but remain focused on executing our U.S. turnaround.

    Frequently Asked Questions About CL

    When is Colgate-Palmolive Company's next earnings date?

    Colgate-Palmolive Company's next earnings report is expected for Jan 28, 2027.

    Did CL beat earnings estimates last quarter?

    Yes. Colgate-Palmolive Company reported EPS of $0.97 for the quarter ended Sep 30, 2026, above the $0.92 estimate, a 5.43% surprise.

    What EPS do analysts expect from CL next quarter?

    The consensus EPS estimate for Colgate-Palmolive Company for the quarter ending Dec 31, 2026 is $1.01 from 21 analysts, with estimates from $0.94 to $1.07.

    How often does CL beat earnings estimates?

    Colgate-Palmolive Company beat the EPS estimate in each of the last 15 quarters, with an average surprise of +4.13%.